Financial Ratios

MANGALAM DRUGS AND ORGANICS LTD.

NSE : MANGALAMBSE : 532637ISIN CODE : INE584F01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE99.700.21 (+0.21 %)
PREV CLOSE ( ) 99.49
OPEN PRICE ( ) 98.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2918
TODAY'S LOW / HIGH ( )98.00 101.00
52 WK LOW / HIGH ( )85.16 132.4
NSE99.950.8 (+0.81 %)
PREV CLOSE( ) 99.15
OPEN PRICE ( ) 99.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18437
TODAY'S LOW / HIGH( ) 98.45 100.60
52 WK LOW / HIGH ( )90.8 132.45
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.8012.4217.675.21-5.07
   CEPS(Rs)7.7418.8923.4710.41-0.60
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)96.0095.1282.6365.6760.44
   Tax Rate(%)42.6329.1229.22-32.00-39.98
Margin Ratios
   Core EBITDA Margin(%)6.8610.8815.087.573.74
   EBIT Margin(%)4.028.6212.705.321.12
   Pre Tax Margin(%)0.596.1510.272.00-2.22
   PAT Margin (%)0.344.367.272.64-3.10
   Cash Profit Margin (%)3.296.639.665.26-0.36
Performance Ratios
   ROA(%)0.376.6411.313.73-3.67
   ROE(%)0.8413.9723.838.27-8.05
   ROCE(%)6.5618.3428.0110.661.76
   Asset Turnover(x)1.081.521.561.421.18
   Sales/Fixed Asset(x)1.602.152.091.861.61
   Working Capital/Sales(x)9.038.2115.4932.2618.19
Efficiency Ratios
   Fixed Capital/Sales(x)0.620.470.480.540.62
   Receivable days45.6140.7844.7333.5844.31
   Inventory Days124.8171.0858.5680.6094.20
   Payable days110.4058.2972.4283.1583.21
Valuation Parameters
   PER(x)121.958.285.625.820.00
   PCE(x)12.635.444.242.92-92.64
   Price/Book(x)1.021.081.200.460.91
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.610.530.570.340.65
   EV/Core EBITDA(x)8.744.883.803.8814.88
   EV/EBIT(x)15.156.164.525.7951.13
   EV/CE(x)0.630.730.840.420.70
   M Cap / Sales0.420.360.410.170.38
Growth Ratio
   Net Sales Growth(%)-17.4717.2536.2524.07-18.54
   Core EBITDA Growth(%)-47.19-15.30133.25148.80-79.04
   EBIT Growth(%)-61.52-20.37193.25472.52-92.93
   PAT Growth(%)-93.54-29.72238.94202.76-140.38
   EPS Growth(%)-93.54-29.72238.94202.76-140.38
Financial Stability Ratios
   Total Debt/Equity(x)0.490.520.490.480.66
   Current Ratio(x)1.251.421.231.091.16
   Quick Ratio(x)0.420.520.690.500.35
   Interest Cover(x)1.173.485.241.600.34
   Total Debt/Mcap(x)0.480.480.411.040.72

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.